When the game changes: guidance to adjust sarcoidosis management during the coronavirus disease 2019 pandemic

NJ Sweiss, P Korsten, HJ Syed, A Syed, RP Baughman… - Chest, 2020 - journal.chestnet.org
Over the past few months, the novel coronavirus disease 2019 (COVID-19) pandemic has
posed many challenges for practicing physicians. Patients with sarcoidosis may have an
increased risk of a poor outcome and death from COVID-19 infection for several reasons.
First, sarcoidosis involves the lung in approximately 90% of patients, 1 many of whom have
diminished baseline lung function with reduced pulmonary reserve should they develop
respiratory failure. Second, although the etiology of sarcoidosis is unknown, it is postulated …
以上显示的是最相近的搜索结果。 查看全部搜索结果